AI Reportedly Key to Moderna's Phase 3 Cancer Vaccine
Posts discuss AI's reported role in selecting mutations for an mRNA therapy by Moderna and Merck.
Polymarket posted that AI reportedly helped design Moderna's personalized skin cancer vaccine after it succeeded in a Phase 3 trial. Other accounts repeated the claim and added that the companies sequence each patient's tumor, compare it to healthy DNA, and use AI to pick mutations most likely to spark an immune response. One reply noted the models are probably small neural networks. Separate posts from founders and investors shared the same headline and expressed excitement about the result.
JUST IN: AI reportedly played a key role in helping design Moderna's personalized skin cancer vaccine, which succeeded in a Phase 3 trial.
Combined views
2.6M
19 posts, first seen
Reactions from ranked influencers
18 postsThis is freaking huge: For the first time, a AI-assisted personalized mRNA cancer treatment has succeeded in a Phase 3 trial. Moderna and Merck sequence each patient’s tumor and compare it with their healthy DNA. AI then helps identify which of the tumor’s mutations are most…
You guys sure you don’t want more data centers?
This is freaking huge: For the first time, a AI-assisted personalized mRNA cancer treatment has succeeded in a Phase 3 trial. Moderna and Merck sequence each patient’s tumor and compare it with their healthy DNA. AI then helps identify which of the tumor’s mutations are most…
We started Kerna on the thesis that mRNA would become a widespread therapeutic modality beyond vaccines. Today, Moderna’s mRNA cancer therapy + Keytruda met its Ph3 endpoints. We’re already building the foundation models and in vivo data engine for what comes next.
@Jason Synthetic RNA will cure many diseases
So this is what happens when you keep telling the model to try again 😍
JUST IN: AI reportedly played a key role in helping design Moderna's personalized skin cancer vaccine, which succeeded in a Phase 3 trial.
Moderna just showed what mRNA can do beyond vaccines: its individualized cancer therapy, with Keytruda, succeeded in Ph3. When LLMs began rapidly progressing 3y ago, we made a bet that AI models can outperform human-led design to create better mRNAs. 🧵1/4
@EricTopol Despite its obvious misuse during Covid, mRNA has tremendous promise for curing diseases. Artificial RNA essentially makes curing diseases a software problem.
JUST IN: AI reportedly played a key role in helping design Moderna's personalized skin cancer vaccine, which succeeded in a Phase 3 trial.